Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
Blood|November 20, 2024
Methylation sequencing enhances interpretation of clonal hematopoiesis dynamicsAlyssa C Parker, Joseph C Van Amburg, J Brett Heimlich, et al.
RSC Chemical Biology|February 27, 2026
Discovery of natural products that modulate signaling in patient-derived cellsJoseph A Balsamo, Hannah L Thirman, Kathryn E Penton, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
MDS-associated SF3B1 mutations promote aberrant fate choice of hematopoietic stem cell via mis-splicing of mediator kinase module component CDK8Elizabeth A Bonner, Tun-Yun Hsueh, Axia Song, et al.
Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.
Experimental Hematology|February 22, 2021
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T Villaume, M Pia Arrate, Haley E Ramsey, et al.
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferaseH S Friedman, A E Pegg, S P Johnson, et al.
Cancer Immunology Research|November 11, 2018
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor TypesAllison R Greenplate, Daniel D McClanahan, Brian K Oberholtzer, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Pageof 15